Definium Therapeutics, Inc. (DFTX)
38.43
-0.25
(-0.65%)
USD |
NASDAQ |
Sep 18, 13:23
Definium Therapeutics Free Cash Flow : -166.74M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -166.74M |
| March 31, 2026 | -145.05M |
| December 31, 2025 | -131.84M |
| September 30, 2025 | -113.82M |
| June 30, 2025 | -101.18M |
| March 31, 2025 | -90.27M |
| December 31, 2024 | -77.45M |
| September 30, 2024 | -73.36M |
| June 30, 2024 | -72.84M |
| March 31, 2024 | -67.05M |
| December 31, 2023 | -63.78M |
| September 30, 2023 | -55.44M |
| June 30, 2023 | -47.47M |
| March 31, 2023 | -48.54M |
| December 31, 2022 | -48.08M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 |
| Date | Value |
|---|---|
| December 31, 2021 | |
| September 30, 2021 | -46.03M |
| June 30, 2021 | -35.93M |
| March 31, 2021 | -29.41M |
| December 31, 2020 | -24.89M |
| September 30, 2020 | -16.80M |
| June 30, 2020 | -10.89M |
| March 31, 2020 | -5.486M |
| August 31, 2019 | -0.523M |
| May 31, 2019 | -0.6714M |
| February 28, 2019 | -0.6612M |
| November 30, 2018 | -1.155M |
| August 31, 2018 | -1.724M |
| May 31, 2018 | -2.108M |
| February 28, 2018 | -2.760M |
| November 30, 2017 | -3.102M |
| August 31, 2017 | -2.888M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cocrystal Pharma, Inc. | -8.276M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -208.80M |
| Fulcrum Therapeutics, Inc. | -66.14M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -52.33M |
| Cash from Investing (Quarterly) | -315.46M |
| Cash from Financing (Quarterly) | 758.70M |
| Free Cash Flow Per Share (Quarterly) | -0.4728 |
| Free Cash Flow to Equity (Quarterly) | -48.03M |
| Free Cash Flow to Firm (Quarterly) | -51.10M |
| Free Cash Flow Yield | -4.29% |